band

Logo

ASPARLAS is available to help treat ALL

ASPARLAS (calaspargase pegol-mknl) is indicated as a component of a multiagent chemotherapeutic regimen for
the treatment of acute lymphoblastic leukemia (ALL) in pediatric and young adult patients aged 1 month to 21 years.

Prescribing Info Order Now FDA Press Release

Logo